A randomized, phase II study of afatinib versus cetuximab in metastatic or recurrent squamous cell carcinoma of the head and neck
| Autor: | Seiwert, T.Y. *, Fayette, J., Cupissol, D., del Campo, J.M., Clement, P.M., Hitt, R., Degardin, M., Zhang, W., Blackman, A., Ehrnrooth, E., Cohen, E.E.W. |
|---|---|
| Zdroj: | In Annals of Oncology September 2014 25(9):1813-1820 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|